PDT+ Cancer Research Results
PDT+, PDT+cells: Click to Expand ⟱
| Source: |
| Type: |
PD-1+Tim-3+terminal CD8+ T cells (PDT+)
-In several studies across different malignancies, high frequencies of PD-1⁺Tim-3⁺ terminal CD8⁺ T cells have been associated with advanced disease stages or an immunosuppressive tumor microenvironment.
-Their accumulation may correlate with a poorer prognosis, as it reflects chronic immune stimulation and subsequent T cell dysfunction.
|
Scientific Papers found: Click to Expand⟱
CD8+↑, As previously reported, hydrogen gas improves the prognosis of patients with cancer by restoring exhausted CD8+ T cells into active CD8+ T cells
OS↑, Median survival time (MST) for the HGN-treated patients was 28 months, a length that is approximately 3-fold longer than that for NO-treated patients (MST 9 months)
eff↝, (PDT+ ratio and CoQ10 ratio, respectively) revealed that patients with low PDT+ ratio (<0.81) and high CoQ10 ratio (>1.175) had significantly longer OS compared with those with high PDT+ ratio and low CoQ10 ratio
CoQ10↑, Hydrogen gas has been suggested to enhance the clinical efficacy of nivolumab by increasing CoQ10 (mitochondria) to reduce PDT+, with PDT+ and CoQ10 as reliable negative and positive biomarkers of nivolumab, respectively.
PDT+↓,
PGC-1α↑, As hydrogen gas is reported to activate PGC1-α (14), it is also one of the mitochondrial activation mediators.
Dose↝, Patients were continuously treated with nivolumab (1 mg/kg) every 2 weeks. Patients also inhaled hydrogen gas 3 h daily at their home through a cannula or mask that they rented or purchased and connected to a Hycellvator ET 100
*toxicity∅, Recently, hydrogen gas inhalation was used in patients with post-cardiac arrest syndrome, and adverse events were not observed
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
CoQ10↑, 1,
Mitochondria & Bioenergetics ⓘ
PGC-1α↑, 1,
Immune & Inflammatory Signaling ⓘ
PDT+↓, 1,
Drug Metabolism & Resistance ⓘ
Dose↝, 1, eff↝, 1,
Functional Outcomes ⓘ
OS↑, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 7
Pathway results for Effect on Normal Cells:
Functional Outcomes ⓘ
toxicity∅, 1,
Total Targets: 1
Scientific Paper Hit Count for: PDT+, PDT+cells
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1316 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page